Strategic Partnerships Collaborate with Harrington Discovery Institute to accelerate rare disease therapeutics via their transatlantic accelerator and Oxford partnership, presenting opportunities for joint clinical development, grant-funded programs, and co-investment ventures.

Rare Disease Focus Target their emphasis on turning discoveries into medicines for rare diseases to offer specialized platform services, regulatory strategy support, and translational research tools tailored to rare patient populations.

Philanthropic Backbone Leverage their strong funding base from the Harrington family and institutional partners to propose multi-year collaborations, sponsored research, and impact-driven partnerships aligned with their Better World vision.

Global Outreach Engage with their international activities, such as the Oxford-Harrington Rare Disease Centre, to propose cross-border clinical trials, data-sharing initiatives, and global supply chain solutions for rare disease programs.

Technical / Enablement Offer scalable cloud and data management, digital collaboration, and e-signature workflows aligned with their tech stack (Azure, Salesforce, Box, SharePoint, DocuSign) to streamline partnerships, grant administration, and research operations.